Trial Profile
A Phase 2 Study Of Perifosine As Second Line Therapy For Advanced Pancreatic Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.